Role of the Bone Marrow Microenvironment in the Development of Multiple Myeloma

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Nikhil C Munshi

Role of Combination Therapy with Novel Targeted Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Tracy L Mcgaha

The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Timothy A Springer

Integrin-Targeted siRNA Delivery for Therapeutic Gene Silencing in Blood Cancers

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Brenda M Birmann

Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis

Multiple myeloma and immunoproliferative diseases

Nikhil C Munshi

Genomics Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Oliver W. Press

CD38 Pretargeted Radioimmunotherapy for Myeloma

Multiple myeloma and immunoproliferative diseases

Conor C Lynch

Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Investigator from VU University Amsterdam

Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Multiple myeloma and immunoproliferative diseases